BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11726640)

  • 1. Angiostatin inhibits pathological but not physiological retinal angiogenesis.
    Drixler TA; Borel Rinkes IH; Ritchie ED; Treffers FW; van Vroonhoven TJ; Gebbink MF; Voest EE
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3325-30. PubMed ID: 11726640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
    O'Reilly MS
    EXS; 1997; 79():273-94. PubMed ID: 9002223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
    McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model.
    Igarashi T; Miyake K; Kato K; Watanabe A; Ishizaki M; Ohara K; Shimada T
    Gene Ther; 2003 Feb; 10(3):219-26. PubMed ID: 12571629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Despite its homology to angiostatin apolipoprotein(a) does not affect angiogenesis.
    Lou XJ; Kwan HH; Prionas SD; Yang ZJ; Lawn RM; Fajardo LF
    Exp Mol Pathol; 1998 Oct; 65(2):53-63. PubMed ID: 9828147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a).
    Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
    Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
    In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
    Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
    Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The inhibitory effects of angiostatin on retinal neovascularization induced by oxygen].
    Sun XF; Zeng SQ; Zhang H; Yang H; Li GG; Li XQ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1732-6. PubMed ID: 15569437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.
    Pozzi A; LeVine WF; Gardner HA
    Oncogene; 2002 Jan; 21(2):272-81. PubMed ID: 11803470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
    Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and role of endostatin in the retina of oxygen-induced retinopathy mouse model].
    Zhang MX; Zhang JJ; Yan M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):614-7. PubMed ID: 16909615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
    Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
    Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of angiostatin on vascular leakage and VEGF expression in rat retina.
    Sima J; Zhang SX; Shao C; Fant J; Ma JX
    FEBS Lett; 2004 Apr; 564(1-2):19-23. PubMed ID: 15094037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitriol is a potent inhibitor of retinal neovascularization.
    Albert DM; Scheef EA; Wang S; Mehraein F; Darjatmoko SR; Sorenson CM; Sheibani N
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2327-34. PubMed ID: 17460298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats.
    Zhang D; Kaufman PL; Gao G; Saunders RA; Ma JX
    Diabetologia; 2001 Jun; 44(6):757-65. PubMed ID: 11440369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis.
    Benelli R; Morini M; Brigati C; Noonan DM; Albini A
    Int J Oncol; 2003 Jan; 22(1):87-91. PubMed ID: 12469189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived cells are differentially involved in pathological and physiological retinal angiogenesis in mice.
    Zou H; Otani A; Oishi A; Yodoi Y; Kameda T; Kojima H; Yoshimura N
    Biochem Biophys Res Commun; 2010 Jan; 391(2):1268-73. PubMed ID: 20006575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.